The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Doubly censored data, as described in Chang and Yang (1987) <doi:10.1214/aos/1176350608>), are commonly seen in many fields. We use EM algorithm to compute the non-parametric MLE (NPMLE) of the cummulative probability function/survival function and the two censoring distributions. One can also specify a constraint F(T)=C, it will return the constrained NPMLE and the -2 log empirical likelihood ratio for this constraint. This can be used to test the hypothesis about the constraint and, by inverting the test, find confidence intervals for probability or quantile via empirical likelihood ratio theorem. Influence functions of hat F may also be calculated, but currently, the it may be slow.
| Version: | 1.1.9 |
| Depends: | R (≥ 3.5) |
| Suggests: | testthat (≥ 3.0.0) |
| Published: | 2023-01-13 |
| DOI: | 10.32614/CRAN.package.dblcens |
| Author: | Mai Zhou [aut], Li Lee [aut], Kun Chen [aut], Yifan Yang [aut, cre, cph] |
| Maintainer: | Yifan Yang <yfyang.86 at hotmail.com> |
| License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
| URL: | https://github.com/yfyang86/dblcens/ |
| NeedsCompilation: | yes |
| In views: | Survival |
| CRAN checks: | dblcens results |
| Reference manual: | dblcens.pdf |
| Package source: | dblcens_1.1.9.tar.gz |
| Windows binaries: | r-devel: dblcens_1.1.9.zip, r-release: dblcens_1.1.9.zip, r-oldrel: dblcens_1.1.9.zip |
| macOS binaries: | r-release (arm64): dblcens_1.1.9.tgz, r-oldrel (arm64): dblcens_1.1.9.tgz, r-release (x86_64): dblcens_1.1.9.tgz, r-oldrel (x86_64): dblcens_1.1.9.tgz |
| Old sources: | dblcens archive |
Please use the canonical form https://CRAN.R-project.org/package=dblcens to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.